First Trust Advisors
NVAX icon

First Trust Advisors’s Novavax NVAX Stock Holding History

First Trust Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.63M Sell
385,699
-23,629
-6% -$212K ﹤0.01% 1740
2026
Q1 		$3.33M Buy
409,328
+112,009
+38% +$1.02M ﹤0.01% 1681
2025
Q4 		$2M Buy
297,319
+102,328
+52% +$771K ﹤0.01% 1884
2025
Q3 		$1.69M Buy
194,991
+105,859
+119% +$824K ﹤0.01% 1910
2025
Q2 		$562K Buy
89,132
+11,251
+14% +$74.5K ﹤0.01% 2235
2025
Q1 		$499K Sell
77,881
-163,236
-68% -$1.35M ﹤0.01% 2241
2024
Q4 		$1.94M Buy
+241,117
New +$2.32M ﹤0.01% 1824
2023
Q2 		– Sell
-610,427
Closed -$4.23M – 2419
2023
Q1 		$4.23M Buy
+610,427
New +$5.62M ﹤0.01% 1314
2022
Q2 		– Sell
-14,310
Closed -$1.05M – 2569
2022
Q1 		$1.05M Sell
14,310
-136,220
-90% -$12.1M ﹤0.01% 2032
2021
Q4 		$21.5M Sell
150,530
-140,621
-48% -$24.2M 0.02% 818
2021
Q3 		$60.4M Buy
291,151
+203,135
+231% +$44.8M 0.06% 407
2021
Q2 		$18.7M Buy
88,016
+57,354
+187% +$10.5M 0.02% 804
2021
Q1 		$5.56M Sell
30,662
-5,396
-15% -$1.08M 0.01% 1168
2020
Q4 		$4.02M Buy
+36,058
New +$3.83M 0.01% 1189
2016
Q4 		– Sell
-179,534
Closed -$7.47M – 2481
2016
Q3 		$7.47M Sell
179,534
-82,875
-32% -$10.7M 0.02% 822
2016
Q2 		$38.2M Buy
262,409
+29,165
+13% +$3.34M 0.12% 185
2016
Q1 		$24.1M Sell
233,244
-443,038
-66% -$47.5M 0.08% 327
2015
Q4 		$113M Buy
676,282
+142,838
+27% +$22M 0.29% 68
2015
Q3 		$75.4M Sell
533,444
-186,595
-26% -$41.8M 0.22% 100
2015
Q2 		$160M Buy
720,039
+14,137
+2% +$2.48M 0.42% 31
2015
Q1 		$117M Buy
+705,902
New +$115M 0.34% 49

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

First Trust Advisors's NVAX Position: Q2 2026 in Review

First Trust Advisors reduced its Novavax (NVAX) stake by 5.8% in Q2 2026, selling an estimated $212K and leaving 385,699 shares worth $3.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1740.

First Trust Advisors first reported a position in NVAX in Q1 2015 and has held it in 21 quarters since. The position peaked at $160M in Q2 2015. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • First Trust Advisors held 385,699 shares of Novavax worth $3.63M as of Q2 2026.
  • First Trust Advisors sold 23,629 Novavax shares in Q2 2026, an estimated $212K.
  • Novavax made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1740 holding.
  • First Trust Advisors first reported a position in Novavax in Q1 2015 and has held it in 21 quarters since.
  • First Trust Advisors's Novavax position peaked at $160M in Q2 2015.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.